January 2016
Antifungal activity of nanofungicide Trifloxystrobin 25% + Tebuconazole 50% against Macrophomina phaseolina
This study was aimed to develop the nanoform of a commercial fungicide Trifloxystrobin 25% + Tebuconazole 50% (75 WG) with broad spectrum of action for improving its antifungal activity against Macrophomina phaseolina. The fungicide commercially available as Trifloxystrobin 25% + Tebuconazole 50% (75 WG) was converted into its nanoform using ball milling method and assessed for its efficacy against the soil borne fungal...
January 2016
Foot-and-mouth disease virus isolates: Candidate strains for trivalent vaccine development in Nigeria
A quality foot and mouth disease (FMD) vaccine is a prerequisite for effective control in addition to other zoosanitary measures and effective biosecurity practices in disease endemic sub-Saharan countries like Nigeria. To ensure an effective control programme by vaccination, countries that practice mass vaccination campaigns need to conduct vaccine matching studies to establish a relationship between prevalent field...
January 2016
Sensitivity and lower protease activity of Candida albicans species isolated from Egyptian cancer patients after exposure to cytotoxic and/or radiotherapy treatment
Oropharyngeal candidiasis is a common disease among cancer patients receiving chemo or radiotherapy which precede systemic candidemia, a life threatening infection. This study investigated the diversity and prevalence of different Candida species among Egyptian cancer patients, evaluated the sensitivity of Candida albicans to the frequently administered antifungal therapies and the effect of different radio and...
Advertisement
Advertisement
